Rinri Therapeutics

Rinri Therapeutics

Biotechnology Research Sheffield, United Kingdom 17 employees
Employees
17
Contacts
1
Emails
1

Rinri Therapeutics Overview

Headquarters
Sheffield, United Kingdom
Industry
Biotechnology Research
Employees
17
Founded
2018
Funding
4.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Rinri Therapeutics

Rinri Therapeutics is a private biotechnology company developing first-in-class cell therapies to restore hearing. Hearing loss affects over 400m people in the world; 90% caused by sensorineural hearing loss (SNHL). There are currently no disease-modifying therapeutics for SNHL patients. Rinri's pioneering technology seeks to reverse SNHL through the regeneration of the damaged sensory cells in the inner ear, the cochlea. Rinri is backed by Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, Pioneer Group and the University of Sheffield.

Rinri Therapeutics Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Rinri Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Terri Gaskell Biomedical and Life Sciences - Cell
Email
David Hipkiss Experienced C-suite Level Life Science
View
Cherith Campbell-Bell Director of Clinical Development
View
Simon Chandler CEO at Rinri Therapeutics
View

Employees by Management Level

Individual contributor 5 profiles
Executive 1 profile
Director 1 profile
Manager 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0
Healthcare 1 1 0

Compare Similar Companies to Rinri Therapeutics